article · IJTLD OPEN

Preference for daily (1HP) vs. weekly (3HP) isoniazid-rifapentine among people living with HIV in Uganda

Allan Musinguzi
Achilles Katamba
Anne Nakitende
Jillian L. Kadota
Jane Nakimuli
David W. Dowdy
Fred Welishe
Christopher A. Berger
Adithya Cattamanchi
Hélène E. Aschmann
Noah Kiwanuka
C. Namale
Josephine Tumuhamye
Lydia Akello
Juliet Kakeeto
Fred C. Semitala

20244 citationsOpen accessMakerere University

Abstract

Both 1HP and 3HP were highly acceptable regimens, with 3HP preferred by most PLHIV. Weekly, rather than daily, dosing appears preferable to shorter duration of treatment, which should inform scale-up and further development of short-course regimens for TB prevention.

Research topics

Pharmacological Effects and Toxicity Studies
HIV/AIDS Research and Interventions
Epilepsy research and treatment

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.5588/ijtldopen.23.0283

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.